Ignite Creation Date:
2024-05-06 @ 2:49 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04436640
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2020-06-15
Brief Title:
A Study to Evaluate the Long-term Safety Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-07
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-15
First Submit QC Date:
June 15 2020
Study First Post Date:
2020-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-12
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL